Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1982 1
1983 2
1984 1
1986 1
1994 1
1997 1
1998 2
2006 1
2007 2
2008 2
2009 2
2010 2
2011 5
2012 5
2013 11
2014 6
2015 4
2016 4
2017 5
2018 5
2019 13
2020 8
2021 5
2022 4
2023 4
2024 6
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Free PMC article. Clinical Trial.
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Alteration of Gut Microbiota in Individuals at High-Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance.
Luo Y, Tong Y, Wu L, Niu H, Li Y, Su LC, Wu Y, Bozec A, Zaiss MM, Qing P, Zhao H, Tan C, Zhang Q, Zhao Y, Tang H, Liu Y. Luo Y, et al. Among authors: su lc. Arthritis Rheumatol. 2023 Oct;75(10):1736-1748. doi: 10.1002/art.42616. Epub 2023 Sep 21. Arthritis Rheumatol. 2023. PMID: 37219936
Role of microRNA-155 in rheumatoid arthritis.
Su LC, Huang AF, Jia H, Liu Y, Xu WD. Su LC, et al. Int J Rheum Dis. 2017 Nov;20(11):1631-1637. doi: 10.1111/1756-185X.13202. Epub 2017 Nov 3. Int J Rheum Dis. 2017. PMID: 29105307 Review.
Targeting IL-34 in inflammatory autoimmune diseases.
Xu WD, Huang AF, Fu L, Liu XY, Su LC. Xu WD, et al. Among authors: su lc. J Cell Physiol. 2019 Dec;234(12):21810-21816. doi: 10.1002/jcp.28946. Epub 2019 Jun 7. J Cell Physiol. 2019. PMID: 31173370 Review.
IRAK family in inflammatory autoimmune diseases.
Su LC, Xu WD, Huang AF. Su LC, et al. Autoimmun Rev. 2020 Mar;19(3):102461. doi: 10.1016/j.autrev.2020.102461. Epub 2020 Jan 7. Autoimmun Rev. 2020. PMID: 31917263 Review.
98 results